BLOG

endpoints

A cell therapy biotech finds a delivery partner; FDA removes clinical hold on Ocugen’s Covid candidate

Umoja Biopharma will pair its so-called VivoVec particles with Lupagen’s Side CAR-T delivery system to target certain cancers, the companies said Monday.